Welcome to BMY

[anonymous]

Previous experience with Pharma M&A: Company bought will undergo layoffs and keep key people on drug development projects... for the time being. New organization will most certainly have consolidation of functions. The advice is best to get resume ready in order to be ahead of it....

 

[anonymous]

Sadly,,,,, get the resume ready.... any shot of leaving early, before the merger and getting a severence package is dead and buried. We are screwed.

 

[anonymous]

Sadly,,,,, get the resume ready.... any shot of leaving early, before the merger and getting a severence package is dead and buried. We are screwed.

So true!
After the acquisition is complete, Bristol-Myers Squibb said it expects to cut $2.5 billion in costs annually by 2022.
Bye bye Summit and all the people there as well as in the field!

 

[anonymous]

BS

Instead of writing two letter reply why don’t you write your version and knowledge of the subject/story unless you are from management

 

[anonymous]

This isn’t true at all. MERCK realigned territories and, in Oncology, only a handful of people lost their jobs. Most Schering people left MERCK on their own.

This is a public service announcement from the management at BS I mean BMS. Watch out folks every man and women for themselves!